# Cordis US Corporation: PMA supplement approved for Cordis Mynx Vascular Closure Portfolio (VCP): MynxGrip, Mynx Control, and Mynx Control Ven

**Score:** 30/100

| Field | Value |
|---|---|
| Sponsor | Cordis US Corporation |
| Product | Cordis Mynx Vascular Closure Portfolio (VCP): MynxGrip, Mynx Control, and Mynx Control Venous Vascular Closure |
| Generic / ingredient | Device, hemostasis, vascular |
| Approval | PMA supplement (device change) |
| Application | P040044 S113 |
| Decided | 2026-05-14 |
| Panel / class | Cardiovascular |
| Sponsor location | Miami Lakes, FL |

## Why this score


Source: openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration) (https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P040044S113). Last refreshed: 2026-11-04T06:06:18.796Z.
From openFDA (PMA and Drugs@FDA). openFDA can lag FDA decisions by days to weeks. Drug supplement types follow the FDA submission class (labeling and REMS, manufacturing/CMC, efficacy, other). Company and product level only. Verify on FDA databases before relying on an approval.